Simplex Trading’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-200
Closed -$6.8K 9011
2025
Q4
$6.8K Buy
+200
New +$6.44K ﹤0.01% 7240
2022
Q1
Sell
-142
Closed -$3K 10328
2021
Q4
$3K Sell
142
-2,250
-94% -$73.8K ﹤0.01% 9789
2021
Q3
$109K Buy
2,392
+59
+3% +$2.47K ﹤0.01% 6491
2021
Q2
$108K Buy
2,333
+2,323
+23,230% +$115K ﹤0.01% 6616
2021
Q1
$56K Buy
10
+4
+67% +$265 ﹤0.01% 6456
2020
Q4
$45K Buy
+6
New +$704 ﹤0.01% 6293
2020
Q2
Sell
-1
Closed -$8K 7552
2020
Q1
$8K Buy
+1
New +$214 ﹤0.01% 6585
2019
Q4
Sell
-2
Closed -$19K 7254
2019
Q3
$19K Buy
2
+1
+100% +$151 ﹤0.01% 5832
2019
Q2
$14K Hold
1
﹤0.01% 5878
2019
Q1
$27K Buy
+1
New +$253 ﹤0.01% 5484
2018
Q4
Sell
-2
Closed -$74K 6958
2018
Q3
$74K Buy
+2
New +$937 ﹤0.01% 4740
2018
Q2
Sell
-5
Closed -$4K 7331
2018
Q1
$4K Sell
5
-19
-79% -$11.8K ﹤0.01% 4746
2017
Q4
$26K Sell
24
-19
-44% -$8.6K ﹤0.01% 3055
2017
Q3
$26K Buy
43
+36
+514% +$11K ﹤0.01% 2912
2017
Q2
$27K Buy
7
+1
+17% +$282 ﹤0.01% 2976
2017
Q1
$27K Sell
6
-4
-40% -$981 ﹤0.01% 2935
2016
Q4
$12K Buy
+10
New +$1.49K ﹤0.01% 3532

Other funds holding ASMB

Simplex Trading's ASMB Position: Q1 2024 in Review

Simplex Trading sold out of Assembly Biosciences (ASMB) in Q1 2024, closing a stake of 6 shares.

Simplex Trading first reported a position in ASMB in Q4 2016 and held it in 20 quarters. The position peaked at $558K in Q4 2017. 24 funds tracked by Wall St. Rank hold ASMB as of Q1 2024.

  • Simplex Trading reported no remaining Assembly Biosciences position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 6 Assembly Biosciences shares in Q1 2024.
  • Simplex Trading first reported a position in Assembly Biosciences in Q4 2016 and held it in 20 quarters.
  • Simplex Trading's Assembly Biosciences position peaked at $558K in Q4 2017.
  • 24 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.